Clinical need absent, unclear in nearly 30 percent of outpatient opioid prescriptions

September 10, 2018, Harvard Medical School
Credit: CC0 Public Domain

Nearly 30 percent of outpatient opioid prescriptions in the United States lack documented clinical reasons that justify the use of these potent drugs, according to a national analysis of physician visit records conducted by researchers at Harvard Medical School and the RAND Corporation.

Results of the report, published Sept. 11 in Annals of Internal Medicine, raise concerns about inappropriate prescribing, lax documentation practices, or a combination thereof, the researchers say.

"Transparency in clinical decision-making is predicated on proper documentation that clearly spells out the reason for giving a patient opioids and can limit inappropriate and curb excessive use of these potent drugs," said senior investigator Nicole Maestas, associate professor of health care policy at Harvard Medical School.

Research has shown that the medical use of opioids has risen dramatically over the past 20 years, outpacing the actual prevalence of —a trend that may be partly fueled by inappropriate prescription practices for conditions that do not warrant treatment with opioids, the researchers say.

"Whatever the reasons, lack of robust documentation undermines our efforts to understand physician prescribing patterns and curtails our ability to stem overprescribing," said study author Tisamarie Sherry, Harvard Medical School instructor in medicine and an associate physician at the Brigham and Women's Hospital and a policy researcher at the RAND Corporation.

Absence of clear documentation, Sherry added, could also be a symptom of deeper systemic issues that prevent physicians' note-keeping such as time pressures or complicated documentation interfaces.

For the study, the researchers analyzed data from the National Ambulatory Medical Care Survey on opioid prescriptions dispensed during doctor's office visits between 2006 and 2015. Along with patient characteristics, the database contains information about medical conditions discussed during each visit.

In total, opioids were given in almost 809 million outpatient visits. Of the visits involving the prescription of an opioid, 5.1 percent were for the treatment of cancer-related pain, while 66.4 percent were for treating noncancer pain. The remaining 28.5 visits were missing any record of pain or a pain-related condition.

Of the visits with noncancer pain diagnoses, the most commonly listed conditions were back pain, diabetes, other chronic, nonspecific pain and arthritis. Of the visits with no pain indication, the most common conditions were high blood pressure, high cholesterol and opioid dependence (2.2 percent). Absence of pain indication was more common in visits in which opioid prescriptions were being renewed (30.5 percent), compared with visits that involved new prescriptions (22.7 percent). That finding, the researchers say, highlights the need for periodic reassessment of the medical need to refill an opioid prescription.

The researchers say their results underscore the need for stricter requirements on documenting the need for opioids—an approach many insurance providers already use to determine approval of new, costly drugs.

Additionally, the authors say, the findings should prompt policymakers to seek ways to simplify clinical documentations systems.

"We must institute robust requirements to document clinical rationale, but we also must enable physicians to comply with them without creating undue administrative burden," Maestas said.

Between 1999 and 2016, more than 630,000 people have died from a drug overdose, according to the Centers for Disease Control and Prevention. Of the more than 63,600 drug overdose deaths in 2016, about two-thirds involved an opioid. On average, 115 Americans die every day from an overdose.

Explore further: Risky opioid prescriptions linked to higher chance of death

Related Stories

Risky opioid prescriptions linked to higher chance of death

June 18, 2018
When patients are prescribed opioids in risky ways, their chance of dying increases and their odds of death go higher as the number of risky opioid prescriptions increase, according to a new RAND Corporation study.

Bigger drop in opioid prescribing after CDC guideline release

August 28, 2018
(HealthDay)—Release of the U.S. Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain in March 2016 corresponded to greater increases in several opioid prescribing patterns, according ...

Study finds racial disparities in prescribing opioids for chronic pain

August 20, 2018
Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain. Black patients who receive opioids long-term are more likely than whites to be tested for illicit ...

Doctors prescribe opioids at high rates to those at increased overdose risk

April 24, 2018
The number of first-time prescriptions for opioid drugs has not risen since about 2010, according to UCLA researchers. However, patients taking a class of drug known to increase the risk for overdoses were likelier to receive ...

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Nearly a quarter of Ontarians newly prescribed opioids received dose exceeding guidelines

May 16, 2018
Nearly a quarter (23.9 per cent) of initial opioid prescriptions in Ontario had a daily dose of more than 50 milligram morphine equivalents (MME), exceeding the suggested dose threshold for opioid prescriptions outlined in ...

Recommended for you

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

One in four older adults prescribed a benzodiazepine goes on to risky long-term use

September 10, 2018
They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression. But prescriptions for sedatives known as benzodiazepines may lead to long-term use among one in four older adults who receive them, ...

Clinical need absent, unclear in nearly 30 percent of outpatient opioid prescriptions

September 10, 2018
Nearly 30 percent of outpatient opioid prescriptions in the United States lack documented clinical reasons that justify the use of these potent drugs, according to a national analysis of physician visit records conducted ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym518498
1 / 5 (2) Sep 10, 2018
doctors are providing opioids for lancing zits, removal of small skin cancers etc etc, totally criminal. Unfortunately patients demand this crap so they can stay high, hell, they will even hurt and maim their pets to get their filthy hands on drugs.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.